Related references
Note: Only part of the references are listed.Age-related inflammatory bone marrow microenvironment induces ineffective erythropoiesis mimicking del(5q) MDS
Y. Mei et al.
LEUKEMIA (2018)
TRAF6 Mediates Basal Activation of NF-κB Necessary for Hematopoietic Stem Cell Homeostasis
Jing Fang et al.
CELL REPORTS (2018)
Disordered Immune Regulation and its Therapeutic Targeting in Myelodysplastic Syndromes
Kathryn S. Ivy et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2018)
Chronic immune response dysregulation in MDS pathogenesis
Laura Barreyro et al.
BLOOD (2018)
Increase of DNA damage and alteration of the DNA damage response in myelodysplastic syndromes and acute myeloid leukemias
Henning D. Popp et al.
LEUKEMIA RESEARCH (2017)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
S. Jaiswal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apcdel/+MDS mouse model
Angela Stoddart et al.
BLOOD (2017)
Gli1+ Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target
Rebekka K. Schneider et al.
CELL STEM CELL (2017)
Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia
Noemi A. Zambetti et al.
CELL STEM CELL (2016)
Massive parallel RNA sequencing of highly purified mesenchymal elements in low-risk MDS reveals tissue-context-dependent activation of inflammatory programs
S. Chen et al.
LEUKEMIA (2016)
Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9
Rebekka K. Schneider et al.
NATURE MEDICINE (2016)
Identification of a common mesenchymal stromal progenitor for the adult haematopoietic niche
Xingbin Hu et al.
NATURE COMMUNICATIONS (2016)
CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)
Erica Bello et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms
Chantana Polprasert et al.
CANCER CELL (2015)
Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling
Melinda E. Varney et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q
M. Heuser et al.
LEUKEMIA (2015)
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
I. Ganan-Gomez et al.
LEUKEMIA (2015)
Cell intrinsic and extrinsic factors synergize in mice with haploinsufficiency for Tp53, and two human del(5q) genes, Egr1 and Apc
Angela Stoddart et al.
BLOOD (2014)
Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice
Angela Stoddart et al.
BLOOD (2014)
Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS
Ganesan Keerthivasan et al.
BLOOD (2014)
Role of Casein Kinase 1A1 in the Biology and Targeted Therapy of del(5q) MDS
Rebekka K. Schneider et al.
CANCER CELL (2014)
Deletion 5q MDS: Molecular and therapeutic implications
Rami S. Komrokji et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2013)
Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic Syndrome
Garrett W. Rhyasen et al.
CANCER CELL (2013)
Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes
Sophie Dimicoli et al.
PLOS ONE (2013)
Tumor necrosis factor restricts hematopoietic stem cell activity in mice: involvement of two distinct receptors
Cornelis J. H. Pronk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice
Mark P. Boldin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche
Andrew Chow et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
NF-κB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies
Jimmy L. Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Apcmin mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS
Steven W. Lane et al.
BLOOD (2010)
Haploinsufficiency of Apc leads to ineffective hematopoiesis
Jianghong Wang et al.
BLOOD (2010)
Innate Immune Signaling in the Myelodysplastic Syndromes
Daniel T. Starczynowski et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Mesenchymal and haematopoietic stem cells form a unique bone marrow niche
Simon Mendez-Ferrer et al.
NATURE (2010)
Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype
Daniel T. Starczynowski et al.
NATURE MEDICINE (2010)
5q-myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics
K. M. Eisenmann et al.
ONCOGENE (2009)
A critical role for Apc in hematopoietic stem and progenitor cell survival
Zhijian Qian et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
Benjamin L. Ebert et al.
NATURE (2008)
Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders
John M. Joslin et al.
BLOOD (2007)
Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes
Christos I. Maratheftis et al.
CLINICAL CANCER RESEARCH (2007)
Role of nucleophosmin in embryonic development and tumorigenesis
S Grisendi et al.
NATURE (2005)
A hypothesis for the pathogenesis of myelodysplastic syndromes: implications for new therapies
C Rosenfeld et al.
LEUKEMIA (2000)
Share Paper
